Mode
Text Size
Log in / Sign up

Clinically Isolated Syndrome

Part of Multiple Sclerosis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Clinically Isolated Syndrome

5 trials tracked for Clinically Isolated Syndrome: 5 in phase 3 or 4.

5Trials tracked
5Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 3 Phase 3 2
  1. Phase 4 Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™ Completed
  2. Phase 4 A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab Completed
  3. Phase 4 A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy Completed
  4. Phase 3 Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) Completed
  5. Phase 3 A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.